Sclerosing cholangitis in the paediatric patient

Area of Science:

• Pediatric Gastroenterology and Hepatology
• Autoimmune Diseases
• Genetic Disorders

Background:

• Sclerosing cholangitis in children is a complex condition with multiple underlying causes.
• Unlike in adults, primary sclerosing cholangitis is uncommon in pediatric populations.
• The specific etiologies and pathogenic mechanisms for different forms remain largely unknown.

Purpose of the Study:

• To delineate the heterogeneous nature of childhood sclerosing cholangitis.
• To highlight the distinct etiologies and clinical presentations of pediatric sclerosing cholangitis.
• To underscore the variability in treatment and prognosis based on the type of sclerosing cholangitis.

Main Methods:

• Review of existing literature on pediatric sclerosing cholangitis.
• Classification of sclerosing cholangitis based on etiology (neonatal, autoimmune, associated disorders).
• Comparative analysis of clinical features, pathogenesis, and outcomes.

Main Results:

• Identified distinct forms: neonatal sclerosing cholangitis, autoimmune sclerosing cholangitis, and sclerosing cholangitis associated with systemic diseases.
• Highlighted the rarity of primary sclerosing cholangitis in children compared to adults.
• Emphasized the obscure initiating events and pathogenic mechanisms across different subtypes.

Conclusions:

• Childhood sclerosing cholangitis is a heterogeneous group of diseases with diverse origins.
• Accurate diagnosis of the specific type is crucial for determining appropriate management and predicting prognosis.
• Further research is needed to elucidate the underlying mechanisms of pediatric sclerosing cholangitis.